Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Hep C Discussion Forum -> Hep C News -> Prime Therapeutics Formulary News
Post Info TOPIC: Prime Therapeutics Formulary News
Matt Chris


Guru

Status: Offline
Posts: 1781
Date:
RE: Prime Therapeutics Formulary News
Permalink  
 

Hey Wayne

Interesting way that both Gilead & Abbvie decided to agree to play fair. one of the articles mentioned that there is no exclusive for either one of the therapy's.

So I would think that both saw a degrading market price because of the competition and worked out a stabilizing price.

Because I am with BCBS / Prime Therapeutics Pharmacy I am seeing in print a actual real time cost reduction, for example my latest Harvoni refill last week says my reduced cost is now $25,673.88 instead of $31,673.88 and that is not the cost Prime Therapeutics pays. Don't' know what the typical mark up for these specialty drugs are but the way the news is being presented sounds like they are getting a much higher discount now. Hopefully we will still see more movement in lesser HCV treatment cost in the coming year.

matt     

 



__________________

"And in the end, the love you take is equal to the love you make"

61 year old Geno type A1, F4 Cirrhotic, started 24 weeks on Harvoni 12-17-14 ,EOT-5 week = UND, 8-31-15 =UND , SVR-24 Baby YES! 
Tig


Admin

Status: Offline
Posts: 9270
Date:
Permalink  
 

Excellent news indeed!! Thanks Wayne...

Tig



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 
OldenSlow


Senior Member

Status: Offline
Posts: 380
Date:
Permalink  
 

"There has been a substantial reduction in the net price of both of these drugs just in the past few weeks, so sometimes it pays not to go first," said Peter Wickersham, senior vice president of Integrated Care and Specialty, Prime. "It was clear that neither Gilead nor AbbVie wanted to be left off our formulary and the result proved to be significantly better than taking an exclusive position."

Article:

Gilead/AbbVie Preferred Status

 

 



__________________

66 y/o male - Geno 1b - F4 cirrhotic dx 2001 - 16 wk treatment w/ Sovaldi/Olysio/Riba - Und @ EOT+24 SVR

 
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.
Hep C Discussion Forum -> Hep C News -> Prime Therapeutics Formulary News
Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.